MedPath
FDA Approval

POSACONAZOLE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Eugia US LLC
DUNS: 968961354
Effective Date
December 26, 2023
Labeling Type
Human Prescription Drug Label
Posaconazole(18 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Eugia Pharma Specialities Limited

Eugia US LLC

650498244

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

POSACONAZOLE

Product Details

NDC Product Code
55150-388
Application Number
ANDA214842
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
April 20, 2022
Code: 6TK1G07BHZClass: ACTIBQuantity: 18 mg in 1 mL
BETADEX SULFOBUTYL ETHER SODIUMInactive
Code: 2PP9364507Class: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath